Evogene Ltd.
EVGN- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- SEC CIK
- 0001574565
In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Evogene Ltd. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 29 | 26 | −3 |
| Shares | 1.61M | 1.46M | −149.5K (−9.3%) |
| Value | $1.25M | $1.21M | −$38.8K (−3.1%) |
New holders (3)
Institutions that held Evogene Ltd. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 96,703 | $80.0K | 0.00% |
| Virtu Financial LLC | 15,290 | $13.0K | 0.00% |
| Simplex Trading, LLC | 484 | $0 | 0.00% |
Sold out (6)
Institutions that held Evogene Ltd. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Vident Investment Advisory, LLC | 87,714 | $68.0K |
| Susquehanna International Group Ltd. | 28,718 | $21.0K |
| Two Sigma Securities, LLC | 10,249 | $8.00K |
| JPMorgan Chase & Co | 4,765 | $4.00K |
| Spire Wealth Management | 1,500 | $1.00K |
| BNP Paribas Arbitrage, SA | 96 | $74 |